Tag Content
SG ID
SG00009751 
UniProt Accession
Theoretical PI
4.5  
Molecular Weight
72287 Da  
Genbank Nucleotide ID
Genbank Protein ID
Gene Name
Sparcl1 
Gene Synonyms/Alias
Ecm2, Sc1 
Protein Name
SPARC-like protein 1 
Protein Synonyms/Alias
Extracellular matrix protein 2; Matrix glycoprotein Sc1;Flags: Precursor 
Organism
Mus musculus (Mouse) 
NCBI Taxonomy ID
10090 
Chromosome Location
chr:5;104508130-104543107;-1
View in Ensembl genome browser  
Function in Stage
Uncertain 
Function in Cell Type
Uncertain 
Probability (GAS) of Function in Spermatogenesis
0.179414811 
The probability was calculated by GAS algorithm, ranging from 0 to 1. The closer it is to 1, the more possibly it functions in spermatogenesis.
Description
Temporarily unavailable 
Abstract of related literatures
1. Sc1 and Sparc are two extracellular proteins sharing similarity in their carboxyl terminus, with 63% identity over a 232-amino-acid region. We have cloned and mapped the genomic locus of mouse Sc1. The mouse Sc1 gene contains 11 exons spanning approximately 35 kb of DNA. The genomic structure (exon/intron boundaries) of Sc1 exons 6 to exon 11 is identical to those of the similar portion of the Sparc gene. This suggests that Sc1 and Sparc originated from a common ancestral gene. Using fluorescence in situ hybridization analysis, Sc1 was localized to band 5E4 of mouse chromosome 5. PMID: [8938431] 

2. A number of cDNAs (SC1, QR1, and hevin) have been shown to be similar to SPARC (secreted protein acidic and rich in cysteine), a matricellular protein that regulates cell adhesion, cell cycle, and matrix assembly and remodeling. These proteins are 61-65% identical in the final 200 residues of their C-termini; their N-terminal sequences are related but more divergent. All have an overall acidic pl, with a follistatin-like region that is rich in cysteine, and a Ca+2 binding consensus sequence at the C-terminus. Using degenerate primers representing the most highly conserved region in SPARC, SC1, and QR1, we identified a 300-BP SC1 clone in a primary polymerase chain reaction (PCR) screen of a mouse brain cDNA library. This cDNA was used to obtain a full-length clone, which hybridized to a 2.8-KB RNA abundant in brain. Mouse SC1 displays a similarity of 70% to mouse SPARC at the amino acid level. Northern blot and RNAse protection assays revealed a 2.8-KB mRNA expressed at moderate levels (relative to brain) in mouse heart, adrenal gland, epididymis, and lung, and at low levels in kidney, eye, liver, spleen, submandibular gland, and testis. In contrast to SPARC, in situ hybridization showed expression of SC1 mRNA in the tunica media and/or adventitia of medium and large vessels; transcripts were not detected in capillaries, venules, or large lymphatics. The distribution of transcripts for SC1 was also different from that of SPARC in several organs, including adrenal gland, lung, heart, liver, and spleen. Moreover, SC1 mRNA was not evident in endothelium cultured from rat heart, bovine fetal and adult aorta, mouse aorta, human omentum, and bovine retina. Cultured smooth muscle cells and fibroblasts also failed to express SC1 mRNA. The absence of SC1 transcript in cultured cells indicates that the SC1 gene is potentially sensitive to regulatory factors in serum or to a three-dimensional architecture conferred by the extracellular matrix that is lacking in vitro. In conclusion, the expression of SPARC and SC1 appears to be coincident in specific tissues (e.g., adrenal gland and brain), but these proteins exhibit distinct expression patterns in most organs of the mouse. Because SC1 and SPARC are structurally similar and exhibit counteradhesive effects on cultured cells, their overlapping and/or adjacent expression in most tissues predicts that one protein might compensate functionally, at least in part, for the other. PMID: [9199668] 

3. The mouse (Mus musculus) is the premier animal model for understanding human disease and development. Here we show that a comprehensive understanding of mouse biology is only possible with the availability of a finished, high-quality genome assembly. The finished clone-based assembly of the mouse strain C57BL/6J reported here has over 175,000 fewer gaps and over 139 Mb more of novel sequence, compared with the earlier MGSCv3 draft genome assembly. In a comprehensive analysis of this revised genome sequence, we are now able to define 20,210 protein-coding genes, over a thousand more than predicted in the human genome (19,042 genes). In addition, we identified 439 long, non-protein-coding RNAs with evidence for transcribed orthologs in human. We analyzed the complex and repetitive landscape of 267 Mb of sequence that was missing or misassembled in the previously published assembly, and we provide insights into the reasons for its resistance to sequencing and assembly by whole-genome shotgun approaches. Duplicated regions within newly assembled sequence tend to be of more recent ancestry than duplicates in the published draft, correcting our initial understanding of recent evolution on the mouse lineage. These duplicates appear to be largely composed of sequence regions containing transposable elements and duplicated protein-coding genes; of these, some may be fixed in the mouse population, but at least 40% of segmentally duplicated sequences are copy number variable even among laboratory mouse strains. Mouse lineage-specific regions contain 3,767 genes drawn mainly from rapidly-changing gene families associated with reproductive functions. The finished mouse genome assembly, therefore, greatly improves our understanding of rodent-specific biology and allows the delineation of ancestral biological functions that are shared with human from derived functions that are not. PMID: [19468303] 

4. The National Institutes of Health's Mammalian Gene Collection (MGC) project was designed to generate and sequence a publicly accessible cDNA resource containing a complete open reading frame (ORF) for every human and mouse gene. The project initially used a random strategy to select clones from a large number of cDNA libraries from diverse tissues. Candidate clones were chosen based on 5'-EST sequences, and then fully sequenced to high accuracy and analyzed by algorithms developed for this project. Currently, more than 11,000 human and 10,000 mouse genes are represented in MGC by at least one clone with a full ORF. The random selection approach is now reaching a saturation point, and a transition to protocols targeted at the missing transcripts is now required to complete the mouse and human collections. Comparison of the sequence of the MGC clones to reference genome sequences reveals that most cDNA clones are of very high sequence quality, although it is likely that some cDNAs may carry missense variants as a consequence of experimental artifact, such as PCR, cloning, or reverse transcriptase errors. Recently, a rat cDNA component was added to the project, and ongoing frog (Xenopus) and zebrafish (Danio) cDNA projects were expanded to take advantage of the high-throughput MGC pipeline. PMID: [15489334] 

5. Kinases play a prominent role in tumor development, pointing to the presence of specific phosphorylation patterns in tumor tissues. Here, we investigate whether recently developed high resolution mass spectrometric (MS) methods for proteome and phosphoproteome analysis can also be applied to solid tumors. As tumor model, we used TG3 mutant mice carrying skin melanomas. At total of 100 microg of solid tumor lysate yielded a melanoma proteome of 4443 identified proteins, including at least 88 putative melanoma markers previously found by cDNA microarray technology. Analysis of 2 mg of lysate from dissected melanoma with titansphere chromatography and 8 mg with strong cation exchange together resulted in the identification of more than 5600 phosphorylation sites on 2250 proteins. The phosphoproteome included many hits from pathways important in melanoma. One-month storage at -80 degrees C did not significantly decrease the number of identified phosphorylation sites. Thus, solid tumor can be analyzed by MS-based proteomics with similar efficiency as cell culture models and in amounts compatible with biopsies. PMID: [19367708] 

Back to Top
Function
 
Back to Top
Subcellular Location
Secreted, extracellular space, extracellularmatrix. 
Tissue Specificity
Highest expression in brain. Moderate levelsin heart, adrenal gland, epididymis and lung. Low levels inkidney, eye, liver, spleen, submandibular gland and testis. 
Gene Ontology
GO IDGO termEvidence
GO:0005615 C:extracellular space IEA:InterPro.
GO:0005578 C:proteinaceous extracellular matrix IEA:UniProtKB-SubCell.
GO:0005509 F:calcium ion binding IEA:InterPro.
GO:0007165 P:signal transduction IEA:InterPro.
Back to Top
Interpro
IPR011992;    EF-hand-like_dom.
IPR018247;    EF_Hand_1_Ca_BS.
IPR018249;    EF_HAND_2.
IPR003645;    Fol_N.
IPR015369;    Follistatin/Osteonectin_EGF.
IPR001999;    Osteonectin_CS.
IPR002350;    Prot_inh_Kazal.
IPR016359;    SPARC-like_p1.
IPR019577;    SPARC/Testican_Ca-bd-dom.
Back to Top
Pfam
PF09289;    FOLN;    1.
PF00050;    Kazal_1;    1.
PF10591;    SPARC_Ca_bdg;    1.
Back to Top
SMART
SM00274;    FOLN;    1.
SM00280;    KAZAL;    1.
Back to Top
PROSITE
PS00018;    EF_HAND_1;    1.
PS50222;    EF_HAND_2;    1.
PS51465;    KAZAL_2;    1.
PS00612;    OSTEONECTIN_1;    1.
PS00613;    OSTEONECTIN_2;    1.
Back to Top
PRINTS
Created Date
18-Oct-2012 
Record Type
GAS predicted 
Sequence Annotation
SIGNAL        1     16       Potential.
CHAIN        17    650       SPARC-like protein 1.
                             /FTId=PRO_0000020313.
DOMAIN      418    440       Follistatin-like.
DOMAIN      436    497       Kazal-like.
DOMAIN      608    643       EF-hand.
CA_BIND     621    632       Potential.
COMPBIAS    192    277       Glu-rich.
COMPBIAS    192    209       Poly-Glu.
MOD_RES      70     70       Phosphoserine.
MOD_RES     411    411       Phosphoserine.
CARBOHYD    148    148       N-linked (GlcNAc...) (Potential).
CARBOHYD    168    168       N-linked (GlcNAc...) (Potential).
CARBOHYD    462    462       N-linked (GlcNAc...) (Potential).
DISULFID    419    430       By similarity.
DISULFID    424    440       By similarity.
DISULFID    442    476       By similarity.
DISULFID    448    469       By similarity.
DISULFID    458    495       By similarity.
DISULFID    501    612       By similarity.
DISULFID    620    636       By similarity.
CONFLICT     25     25       S -> F (in Ref. 2; AAC53172).
CONFLICT     59     59       S -> N (in Ref. 1; AAB06444/AAB08451, 2;
                             AAC53172 and 4; AAH03759).
CONFLICT    199    199       D -> E (in Ref. 1; AAB06444/AAB08451).
CONFLICT    281    281       A -> S (in Ref. 1; AAB06444/AAB08451).
CONFLICT    385    385       R -> Q (in Ref. 1; AAB06444/AAB08451).
Back to Top
Nucleotide Sequence
Length: 830 bp   Go to nucleotide: FASTA
Protein Sequence
Length: 650 bp   Go to amino acid: FASTA
The verified Protein-Protein interaction information
UniProt
Gene Symbol Ref Databases
AppIntAct 
PrnpMINT 
Other Protein-Protein interaction resources
String database  
View Microarray data
Comments